normative
Regulatory framework built for blockbuster drugs
FDA and regulatory agencies are designed around blockbuster drugs used by millions, so the economics fail for ultra-rare disorders: a treatment costing around $100 million to develop may have only five patients worldwide, and the framework needs to change.
normativepending
Speaker
Jeff CollerEvidence Quote
“The economic model just doesn't work. So the FDA is really designed on that blockbuster drug mentality”
Created: 11/17/2026, 7:10:08 AM
Your notes
Loading notes...